Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Histopathology ; 61(3): 454-64, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22687056

ABSTRACT

AIMS: To evaluate the clinicopathological features of small cell carcinoma arising outside the lung. METHODS AND RESULTS: Thirty-seven cases with a pathology diagnosis of extrapulmonary small cell carcinoma (EPSCC) were selected. The clinical notes were reviewed and tumour blocks were selected for a fresh haematoxylin and eosin (H&E) section and immunohistochemical stains. The most common tumour locations were cervix and bladder. Twenty-five cases (68%) were finally diagnosed as EPSCC, nine of which were found with coexisting non small cell carcinoma. Two cases (5%) were diagnosed as large cell neuroendocrine carcinoma (LCNEC) of the cervix. The remainder was classified as 10 poorly differentiated carcinomas (PDCs) (27%). Positive staining for thyroid transcription factor 1 (TTF-1) was noted in nine cases of EPSCC and in none of the cases of PDC (P = 0.034). Synaptophysin immunoreactivity was found in 20 cases of EPSCC and two cases of PDC with neuroendocrine differentiation (P = 0.002), as well as two cases of LCNEC. 34ßE12 was positive in eight cases of SCC and two cases of PDC. CONCLUSIONS: Based on this series, EPSCC may be overdiagnosed. Immunohistochemistry for TTF-1, used in combination with synaptophysin, may help to discriminate EPSCC from PDC.


Subject(s)
Biomarkers, Tumor/analysis , Carcinoma, Small Cell/diagnosis , Adolescent , Adult , Aged , Carcinoma, Small Cell/metabolism , DNA-Binding Proteins/biosynthesis , Diagnosis, Differential , Female , Humans , Immunohistochemistry , Male , Middle Aged , Synaptophysin/biosynthesis , Transcription Factors , Young Adult
2.
Histopathology ; 56(3): 331-44, 2010 Feb.
Article in English | MEDLINE | ID: mdl-20459533

ABSTRACT

AIMS: To assess semiquantitative immunohistochemistry as used in the diagnosis of Lynch syndrome. METHODS AND RESULTS: Tumour sections from 51 mutation carriers and 17 controls were stained with antibodies against MLH1, MSH2, MSH6 and PMS2. Intensity of immunoreactivity and percentage positivity were recorded on scales of 0-3 and 0-4, respectively. These scores were multiplied for a score of 0-12 per slide. Receiver-operator characteristic (ROC) curves of staining performance for the identification of mutation carriers were evaluated, and optimum cut-offs calculated. The area under the MLH1 ROC curve was 0.981 [95% confidence interval (CI) 0.952, 1.000]. The area under the MSH2 ROC curve was 0.899 (95% CI 0.796, 1.000). For MLH1 staining, a score

Subject(s)
Adaptor Proteins, Signal Transducing/biosynthesis , Adenosine Triphosphatases/biosynthesis , Colorectal Neoplasms, Hereditary Nonpolyposis/diagnosis , DNA Repair Enzymes/biosynthesis , DNA-Binding Proteins/biosynthesis , Immunohistochemistry/methods , MutS Homolog 2 Protein/biosynthesis , Nuclear Proteins/biosynthesis , Adaptor Proteins, Signal Transducing/genetics , Adenosine Triphosphatases/genetics , Area Under Curve , Biomarkers, Tumor/analysis , Colorectal Neoplasms, Hereditary Nonpolyposis/genetics , Colorectal Neoplasms, Hereditary Nonpolyposis/metabolism , DNA Repair Enzymes/genetics , DNA-Binding Proteins/genetics , Female , Heterozygote , Humans , Male , Mismatch Repair Endonuclease PMS2 , MutL Protein Homolog 1 , MutS Homolog 2 Protein/genetics , Nuclear Proteins/genetics , ROC Curve , Sensitivity and Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...